INTRODUCTION
The phosphorylation of a number of fat-cell proteins on serine/ threonine residues is increased within a few minutes of exposure of the cells to insulin [for reviews see Denton (1986) and Avruch et al. (1985) ]. One of these proteins migrates on SDS/PAGE with an apparent molecular mass of 22 kDa Belsham et al., , 1982 Blackshear et al., 1982; Diggle et al., 1991; Diggle and Denton, 1992) . This phosphoprotein has a number of interesting characteristics: it is heat-stable and acidsoluble, is poorly stained with Coomassie Blue, and runs as a doublet on one-dimensional SDS/PAGE (three or more individual species are separable by two-dimensional SDS/PAGE). These properties are shared in varying degrees by a number of important regulatory proteins in cells, such as calmodulin, myosin light chains, phosphatase inhibitors 1 and 2 and low-molecularmass guanine-nucleotide-binding proteins (Diggle and Denton, 1992) .
Further studies have indicated that the protein may be present in muscle, liver and various cell lines (Vargas et al., 1982; Blackshear et al., 1983; Blackshear, 1986; Witters et al., 1988) , and that its phosphorylation may also be increased by epidermal growth factor, platelet-derived growth factor and phorbol esters (Blackshear et al., 1983 Diggle and Denton, 1992) . We have also obtained evidence that the protein may be a substrate for casein kinase 2, which raises the possibility that the increased phosphorylation of the protein in rat epididymal fat-cells exposed to insulin may in part be brought about through the activation the peptides (AGGDESQFEMD). The antibody was found to be highly specific for the phosphorylated and non-phosphorylated forms of the acid-soluble 22 kDa protein in Western blots and by immunoprecipitation. Studies with the antibody preparation have shown that both phosphorylated and non-phosphorylated forms of the protein appear to be exclusively located in the cytoplasm, and that exposure of cells to isoprenaline causes increased phosphorylation of the same acid-soluble 22 kDa protein as does insulin treatment. 4. Western blots carried out with the antibody preparation indicate that the protein is also present in other insulin-sensitive tissues, including liver, skeletal muscle, heart and brown adipose tissue. The protein was also detected in lung and spleen, but not brain and kidney. It is concluded that the protein may play an important role in some of the actions of insulin.
of casein kinase 2, as insulin increases the activity of casein kinase 2 in these cells (Diggle et al., 1991) .
Phosphopeptide and phosphoamino acid analysis has indicated that insulin increases the phosphorylation of at least two distinct peptides derived from the protein (in one peptide insulin increases the amount of phosphothreonine, whereas in the other the hormone increases the amounts of phosphoserine and phosphothreonine) (Diggle and Denton, 1992) . Since the individual phosphorylated components separated by SDS/PAGE have similiar phosphopeptide patterns, their differences in migration do not appear to be the result of differences in phosphorylation (Diggle and Denton, 1992) , as suggested previously (Blackshear et al., 1983) . Another area of controversy has been the effects of adrenergic agonists. We find that these and other agents which increase cyclic AMP enhance the phosphorylation of the protein, but only to about half the extent of the effect of insulin Belsham et al., , 1982 Diggle and Denton, 1992) . In contrast, Blackshear et al. (1982 Blackshear et al. ( , 1983 failed to observe this effect.
In this paper, we report the N-terminal sequences obtained from six tryptic peptides derived from the protein purified by microbore h.p.l.c. and the subsequent preparation of a rabbit anti-peptide antibody based on one of these sequences. This antibody is highly specific for the protein and has been used to explore further and to characterize the multiple forms of the protein, its tissue distribution and phosphorylation by insulin and isoprenaline (isoproterenol). Some aspects of this paper have been published in abstract form (Diggle et al., 1994) . While this Abbreviation used: PVDF, polyvinylidene difluoride. * To whom correspondence should be addressed.
paper was in preparation, Hu et al. (1994) reported the molecular cloning of a protein containing 117 amino acids, designated PHAS-I (phosphorylated heat-and acid-stable protein regulated by insulin), which has many similiar properties, but which they concluded is distinct from the protein purified and studied in this laboratory. This conclusion is based partly on the fact that the protein does not contain a consensus sequence for cyclic-AMPdependent protein kinase, and is not phosphorylated in response to increases in cellular cyclic AMP, and partly on the apparent differences in amino acid composition. General techniques SDS/PAGE was performed by the method of Laemmli (1970) , adapted to a Bio-Rad Protean II mini-gel system using 150% (w/v) polyacrylamide gels. Radioautography was performed at -70°C using pre-flashed film in cassettes with intensifying screens . Densitometry was performed using a Joyce-Loebl Chromoscan 3 linked to a Hewlett-Packard 9000/300 computer (Brownsey et al., 1979) . Protein estimations were performed by the method of Bradford (1976) .
Incubation of epididymal fat-pads and fat-cells and preparation of tissue extracts Epididymal fat-pads were preincubated at 37°C for 15 min in gassed bicarbonate-buffered medium, pH 7.4 (Krebs and Henseleit, 1932) containing 10 mM Hepes and 1 mM glucose, or for 2 h in the same medium plus [32P]Pi (initially 0.4 mM and 1000 c.p.m./pmol). Insulin (83 nM) or isoprenaline (9 ,uM) was then added, and incubations were continued as indicated. Fatcells were prepared from rat epididymal fat-pads as described by Diggle et al. (1991) . Cells were incubated in medium without [32P]P, but with albumin (10 mg/ml) and other additions as indicated. After incubation, pads were extracted by homogenizing two pads (Polytron PT1O; Borthwick et al., 1990) in 2 ml of ice-cold extraction buffer [10 mM Tris, pH 7.4, containing 20 mM Mops, 250 mM sucrose, 2 mM EGTA, 1 mM GSH, the proteinase inhibitors pepstatin, antipain and leupeptin (each 1 ,ug/ml) and 2 mM benzamidine]. A post-mitochondrial fat-pad supernatant was prepared by successive centrifugations at 3000 g for 1.5 min and 25000 g for 10 min. Fat-cells were extracted after incubation, by vortex-mixing in 1 ml of extraction buffer. Highspeed fat-cell supernatant was prepared by successive centrifugations at 3000 g for 1.5 min and 150000 g for 60 min. A nuclear fraction was prepared by extraction of the 3000 g fat-cell pellet in extraction buffer (above) containing 0.1 % (v/v) Triton X-100 and 0.4 mM NaCl; a mitochondrial/microsomal fraction was prepared by extraction of the 150000 g fat-cell pellet in extraction buffer containing 0.1 % Triton X-100.
Preparation of a 1.5-15%-(w/v)-trichloroacetic acid fraction containing the 22 kDa protein Acid-soluble fractions containing the 22 kDa protein were prepared from cell fractions as described by Diggle and Denton (1992) .
Large-scale preparation of the acid-soluble 22 kDa protein for amino acid sequencing Acid-soluble 22 kDa protein was purified from epididymal fatpads of 300 or 353 rats incubated in the presence of insulin as described (Diggle and Denton, 1992) . Fat-pads of 10 or 4 rats had been incubated in the presence of [32p]p1 (initially 0.4 mM and 1000 c.p.m.), so that the radiolabelled protein could be followed throughout the preparation. The 22 kDa protein eluted from SDS/polyacrylamide gels was concentrated by using a Centricon-10 micro-concentrator and further decreased to about 50,l by using a Savant Speedivac before separation by h.p.l.c. (Brownlee; C8, Aquapore OD-300, 2.1 mm diam., 7,um particles). The fractions containing the acid-soluble 22 kDa protein were rechromatographed on the same column by using a decreased flow rate and slightly flattened gradient to ensure purity. Immunoprecipitation of acid-soluble 22 kDa protein by antipeptide antibody A sample containing acid-soluble 22 kDa protein was incubated (in the presence of 20 mM EDTA and 50 mM NaF) with rabbit anti-peptide antibody at a final dilution of 1/100 and 5 mg of Sepharose CL 4B linked to Protein A for a minimum of 2 h at 4°C with tumbling. Sepharose beads were pelleted by brief centrifugation and washed twice in 50 mM Hepes buffer, pH 7.4, containing 20 mM EDTA, 50 mM NaF, 1 ,ug/ml each pepstatin, antipain and leupeptin, and 2 mM benzamidine, followed by one wash in one-tenth concentration of the same buffer. Acid-soluble protein was eluted from the Sepharose pellets by boiling for 5 min in 100 ,ul of one-tenth concentration SDS/PAGE sample buffer, followed by one wash in an equivalent volume of water. Sample volumes were decreased by drying in a Savant Speedivac before separation by SDS/PAGE.
Cell culture 3T3-L1 fibroblasts obtained from American Type Culture Collection were cultured in Dulbecco's modified Eagle's medium and differentiated to adipocytes by treatment with insulin, dexamethasone and isobutylmethylxanthine. CHO.T cells, transfected with human insulin-receptor cDNA, and COS-7 cells were grown as described previously (Ellis et al., 1986; Zhang et al., 1991) . All cells were grown in 35 mm-diameter dishes, washed before use and incubated in serum-free medium containing 25 mM glucose, followed by further washing as described by Palfreyman et al. (1992) . After incubation with 83 nM insulin for 30 min, all cells were extracted in ice-cold extraction buffer, and post-mitochondrial supernatants were prepared as for fat-cells. Table I lists the amino acid sequences obtained from peptides derived from the digestion of purified acid-stable 22 kDa protein by trypsin. All six sequences were obtained from the same preparation of the protein from the epididymal adipose tissue. In a previous preparation, peptides 3, 4 and 6 were also sequenced; identical sequences were obtained, except that the fourth amino Figure 1 Western blot of subcellular fractions derived from rat fat-cells previously incubated in the absence (lanes 1, 3, 5) or presence (lanes 2, 4, 6) of insulin, using an anti-peptide antibody
RESULTS

Peptide sequencing
The blot was developed using chemiluminescence. Samples were prepared from high-speedsupernatant (lanes 1, 2), mitochondrial/microsomal (lanes 3, 4) and nuclear (lanes 5, 6) fractions. See the Experimental section for further details. Figure 2 (panels c and d) and in Figure 3 (lanes 1 and 2). The effects of insulin and the fl-agonist isoprenaline are compared in Figure 2 . In agreement with our earlier studies (Diggle and Denton, 1992) , both insulin and isoprenaline caused increases in the phosphorylation of the acid-soluble 22 kDa protein (Figure 2a) , with the effect of isoprenaline being less than that of insulin. The phosphorylated protein migrates as a poorly resolved doublet, which appears to correspond to the upper two bands detected by Western blots (Figure 2c ). Figure 2(b) shows that the antibody is able to precipitate most of the radiolabelled 22 kDa phosphoprotein from extracts of cells treated with either insulin or isoprenaline. The proportion immunoprecipitated was estimated in a number of separate experiments by densitometric scanning of radioautographs. The proportions immunoprecipitated, given as mean+S.E.M. for 3-5 experiments, were 80 + 4 % (control), 78 + I (insulin) and 89 + 1 % (isoprenaline). This is the clearest evidence that the antibody recognizes the acid-stable 22 kDa protein which exhibits increased phosphorylation in cells exposed to either hormone. The small amount of radiolabelled 22 kDa phosphoprotein remaining in the supernatants after immunoprecipitation may be an unrelated protein, as its phosphorylation is unaffected by the addition of either insulin or isoprenaline. Isoprenaline also causes a change in the pattern of 22 kDa proteins recognized by Western blots, but the change, like that in phosphorylation, is not as marked as that with insulin in experiments carried out in both fat-cells ( Figure  2c ) and fat-pads (Figure 2d) . We estimated the amount of 22 kDa protein precipitated by the antibody to be 90 + 20% (mean+S.E.M. of 8 observations) under the conditions used. This was determined by preparing acid-soluble fractions from supernatant after immunoprecipitation and then carrying out densitometric scanning of Western blots of the fractions.
We have used the anti-peptide antibody to explore the presence of the acid-stable 22 kDa protein in other tissues. Figure 3 shows the results of Western blots carried out both on whole tissue extracts using the peroxidase-diaminobenzidine system (panel a) or on acid-soluble fractions using chemiluminescence (panel b). Both protocols showed that the protein is present in liver, heart, skeletal muscle (gastrocnemius), spleen, and perhaps lung. Other studies showed that the protein is also present in rat interscapular brown adipose tissue and the mammary tissue of lactating mouse. The protein could not be detected in either kidney or brain. Figure 4 shows Western blots carried out on equivalent amounts of whole-cell extracts of differentiated 3T3-L1 adipocytes, transfected Chinese-hamster ovary cells which express human insulin receptors (CHO-T cells) and COS-7 cells. The protein could only be detected in the 3T3-LI cells under these conditions. In these cells insulin caused a marked change in band pattern similar to that observed in rat fat-cells (lanes I and 2).
DISCUSSION
The six tryptic peptides found in our preparations of purified acid-stable 22 kDa protein from rat epididymal adipose tissue are all present in the protein designated PHAS-I by Hu et al. (1994) (Table 1) . In contradiction to their conclusion, the proteins are almost certainly the same or extremely similar. The apparent differences in amino acid composition given in Diggle and Denton (1992) (Diggle and Denton, 1992) . Given that the protein migrates very anomalously, it is possible that small variations in amino acid sequence may result in slight differences in migration during SDS/PAGE. The antibody raised against peptide 4, which corresponds to the C-terminal end of the PHAS-I sequence, interacts with up to three distinct bands of 22 kDa protein in Western blots of extracts derived from rat epididymal fat-cells or fat-pads. The ratio of the bands is altered if the cells or pads have been exposed to insulin and to a lesser extent if the cells or pads have been exposed to isoprenaline. The change of pattern correlates with the increases in phosphorylation, with the upper bands corresponding to the bands into which most radiolabelled phosphate is incorporated. Our previous studies (Diggle and Denton, 1992) showed that the three phosphorylated forms which are separated by two-dimensional SDS/PAGE all gave identical phosphopeptide maps. Overall, our observations are consistent with the acid-soluble 22 kDa protein being present in the cytoplasm in two or more isoforms, which are poorly phosphorylated in the absence of insulin and give rise to the doublet on one-dimensional SDS/PAGE. In the presence of hormones, a substantial proportion of each protein becomes phosphorylated, resulting in further, slightly slower migrating, forms. If the assumption is made that the antibody interacts equally with all forms, then it appears that insulin treatment results in the phosphorylation of about half of the 22 kDa protein.
The Western blots and immunoprecipitation studies of Figure  2 strongly support our earlier view (Diggle and Denton, 1992) that the 22 kDa acid-soluble protein which exhibits increased phosphorylation in cells incubated in the presence of isoprenaline is the same protein as that phosphorylated in the presence of insulin. The lack of a consensus cyclic-AMP-dependent protein kinase phosphorylation site in the protein (Hu et al., 1994) is in agreement with our previous finding that the protein is not a substrate for this kinase (Diggle and Denton, 1992) . Increases in intracellular cyclic AMP, and hence in the activity of cyclic-AMP-dependent protein kinase, may result in modest increases in phosphorylation of the protein, either through a decrease in phosphatase activity or through the indirect activation of the protein kinase or kinases which act on the protein, such as casein kinase 2.
If the protein plays a role in the actions of insulin, it would be expected that the protein should be present in other insulinsensitive tissues. Our studies have shown this to be the case for liver, heart, skeletal muscle, brown adipose tissue and mammary tissue. We were unable to detect the protein in brain and kidney. Hu et al. (1994) reported that the highest levels of mRNA for PHAS-I were in adipose tissue and skeletal muscle. The presence of substantial amounts of the protein in differentiated 3T3-LI adipocytes is expected from the extensive studies of Blackshear et al. (1983, 1985) . The low levels of the protein in other cell lines such as CHO and COS may explain in part the difficulty in demonstrating some of the effects of insulin in these cells even after transfection so that the cells express large numbers of insulin receptors.
Note added in proof (received 23 November 1994) Since this paper was submitted, it has been reported that binding of PHAS-I to eukaryotic initiation factor-4E (eIF-4E) inhibits translation of capped-dependent mRNA. Phosphorylation of the former in response to insulin results in decreased binding to eIF-4E, and hence may be important in regulation of translation Lin et al., 1994 
